Renaissance Technologies’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Renaissance Technologies’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-327,271	Closed	-$2.18M	–	4244
2023 Q3	$2.18M	Buy	327,271 +136,296	+71%	+$1.13M	﹤0.01%	1810
2023 Q2	$1.73M	Sell	190,975 -100,725	-35%	-$888K	﹤0.01%	2089
2023 Q1	$2.12M	Buy	291,700 +268,000	+1,131%	+$1.99M	﹤0.01%	1989
2022 Q4	$173K	Sell	23,700 -16,000	-40%	-$119K	﹤0.01%	3471
2022 Q3	$307K	Buy	+39,700	New	+$337K	﹤0.01%	3204

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Renaissance Technologies's PNT Position: Q4 2023 in Review

Renaissance Technologies sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 327,271 shares — an estimated $2.18M sold.

Renaissance Technologies first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $2.18M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Renaissance Technologies reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Renaissance Technologies sold 327,271 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $2.18M.
Renaissance Technologies first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Renaissance Technologies's POINT Biopharma Global Inc. Common Stock position peaked at $2.18M in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.